StockNoteStockNote
Nghe An Pharmaceutical - Medical Supplies Joint Stock Company (NTF), was established on the basis of merging Nghe An Pharmacy and Nam Bac Pharmaceutical Company in 1960. In 2002, Converted to the form of a joint-stock company. The company's main business is the production and trading of pharmaceuticals, cosmetics and medical equipment. The company has 3 production machines, 3 warehouses and 1 office in Vinh City, Nghe An Province. The distribution network includes 1 Pharmaceutical - Cosmetic Trade Center in Nghe An, 19 Pharmaceutical branches in the province, 1 branch in Hanoi, retail system of 545 counters and 200 agents. In terms of business size, NAPHAR is at the average level of the industry; In terms of revenue, the company is quite high compared to enterprises producing and distributing drugs across the country. On July 4, 2019, NTF officially traded on UPCoM market.
NTF currently has a market capitalization of roughly VND 180 billion, placing it in the small-cap group on the Vietnamese stock market. Its current P/E of 55,8x is 9% below its own 6-year average (61,2x), suggesting the stock is trading cheaper than its historical norm. P/B stands at 1x, 42% below its multi-year average of 1,7x. Return on equity (ROE) is at 3,6%, up from 2,6% the year before. Its debt-to-equity ratio of 0x is low, reflecting a conservative capital structure. In 2025, revenue fell 18% year-on-year while after-tax profit grew 37%.
This note is generated automatically from the stock's real financial data, for reference only — not investment advice.
Unit: VND billion. Growth (%) vs. previous period.
Unit: VND billion. Year-end values; current year uses latest session.
Unit: x. Financial debt over shareholders' equity.
Data aggregated from cafef.vn and VNDirect, for reference only, not investment advice.